Skip to main content

Advertisement

SpringerLink
Log in

Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale and objectives

The present study investigated possible genetic association between some polymorphisms possibly involved in antidepressant response and the occurrence of manic or hypo-manic switches during antidepressant treatment.

Methods

We retrospectively examined 169 individuals with a diagnosis of bipolar disorder (BP) type I (n=103) and II (n=66), who presented at least one sudden manic or hypo-manic episode (according to DSM IV criteria) during antidepressant therapy, that occurred within a period of 3 weeks from the beginning of the treatment and without any interposed period of well being (“manic switch”). They were compared with a sex, age, and ethnicity-matched group of 247 subjects, randomly selected from our pool of bipolar subjects, who never showed switches. We then randomly selected from the whole sample (“switched” and “not switched”) a sub-sample of patients not under mood stabiliser treatment at the time of the index episode (65 “switched” and 117 “not switched”) and compared them with a sex, age and ethnicity matched group of 133 subjects, randomly selected from our pool of major depressed patients, who did not present manic switches. The functional polymorphism in the upstream regulatory region of the serotonin transporter (SERTPR), tryptophan hydroxylase (TPH), G-protein beta 3 subunit (Gbeta3), monoamine oxidase A (MAO-A), catechol-O-methyltransferase (COMT), serotonin receptor 2A (5-HT2A), dopamine receptor D2 (DRD2) and dopamine receptor D4 (DRD4) gene variants were analysed using PCR-based techniques.

Results and conclusions

The distribution of the genetic polymorphisms was not significantly different between switched and not-switched patients (P>0.006—Bonferroni corrected). Moreover, no significant difference was found between switched and not switched sub-samples and the sample of major depressed subjects. Further studies are required to investigate other possible related genetic variants influencing the timing of manic-depressive cycle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akiskal HS, Hantouche EG, Allilaire JF, Sechter D, Bourgeois ML, Azorin JM, Chatenet-Duchene L, Lancrenon S (2003) Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord 73:65–74

    Article  PubMed  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington D.C.

  • Angst J (1985) Switch from depression to mania—a record study over decades between 1920 and 1982. Psychopathology 18:140–154

    CAS  PubMed  Google Scholar 

  • Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toru M (1994) Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703–704

    Article  CAS  PubMed  Google Scholar 

  • Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol H (1995) Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65:1157–1165

    CAS  PubMed  Google Scholar 

  • Benedetti F, Campori E, Barbini B, Fulgosi MC, Colombo C (2001) Dopaminergic augmentation of sleep deprivation effects in bipolar depression. Psychiatry Res 104:239–246

    Article  CAS  PubMed  Google Scholar 

  • Benkelfat C (1993) Serotoninergic mechanisms in psychiatric disorders: new research tools, new ideas. Int Clin Psychopharmacol 8:53–56

    Google Scholar 

  • Berrettini W (1998) Progress and pitfalls: bipolar molecular linkage studies. J Affect Disord 50:287–297

    Article  CAS  PubMed  Google Scholar 

  • Boerlin HL, Gitlin M, Zoellner LA, Hammen CL (1998) Bipolar depression and antidepressant-induced mania—a naturalistic study. J Clin Psychiatry 59:374–379

    CAS  PubMed  Google Scholar 

  • Bottlender R, Rudolf D, Strauss A, Moller HJ (2001) Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 63:79–83

    Article  CAS  PubMed  Google Scholar 

  • Bunney WE Jr (1975) The current status of research in the catecholamine theories of affective disorders. Psychopharmacol Commun 1:599–609

    CAS  PubMed  Google Scholar 

  • Bunney WE Jr, Goodwin FK, Murphy DL, House KM, Gordon EK (1972) The “switch process” in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry 27:304–309

    PubMed  Google Scholar 

  • Chee IS, Lee SW, Kim JL, Wang SK, Shin YO, Shin SC, Lee YH, Hwang HM, Lim MR (2001) 5-HT2A receptor gene promoter polymorphism −1438A/G and bipolar disorder. Psychiatr Genet 11:111–114

    Article  CAS  PubMed  Google Scholar 

  • Chen G, Manji HK, Wright CB, Hawver DB, Potter WZ (1996) Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology 15:271–280

    Article  CAS  PubMed  Google Scholar 

  • Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E (1999) Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res 86:267–270

    Article  CAS  PubMed  Google Scholar 

  • Craddock N, Dave S, Greening J (2001) Association studies of bipolar disorder. Bipolar Disord 3:284–298

    Article  CAS  PubMed  Google Scholar 

  • Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Smeraldi E (2002) Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am J Med Genet 114:380–390

    Article  PubMed  Google Scholar 

  • De Luca V, Mundo E, Trakalo J, Wong GW, Kennedy JL (2003) Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. Pharmacogenomics J 3:297–299

    Article  PubMed  Google Scholar 

  • Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624

    Article  CAS  PubMed  Google Scholar 

  • Dimitrova A, Georgieva L, Nikolov I, Poriazova N, Krastev S, Toncheva D, Owen MJ, Kirov G (2002) Major psychiatric disorders and the serotonin transporter gene (SLC6A4): family-based association studies. Psychiatr Genet 12:137–141

    Article  PubMed  Google Scholar 

  • Dolberg OT, Schreiber S, Grunhaus L (2001) Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry 49:468–470

    Article  CAS  PubMed  Google Scholar 

  • Endicott J, Spitzer R (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844

    CAS  PubMed  Google Scholar 

  • Falk CT, Rubinstein P (1987) Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227–233

    PubMed  Google Scholar 

  • First MB, Spitzer RL, Gibbon M, Williams JB (1995) Structured clinical interview for DSM-IV axis I disorders—patient edition (SCID—I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York

  • Franchini L, Serretti A, Gasperini M, Smeraldi E (1998) Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 32:255–259

    Article  CAS  PubMed  Google Scholar 

  • Fuciarelli M, Vienna A, Paba E, Bastianini A, Sansonetti B, Capucci E, Destefano GF (1997) PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy. Am J Hum Biol 9:629–646

    Article  Google Scholar 

  • Goodwin F, Jamison K (1990) Manic-depressive illness. Oxford University Press, New York

  • Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M (2001) Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 62:249–255

    CAS  PubMed  Google Scholar 

  • Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC (2000) Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 96:36–42

    Article  CAS  PubMed  Google Scholar 

  • Jacobs BL, Fornal CA (1995) Serotonin and behavior. A general hypothesis. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 461–469

  • Joffe RT, MacQueen GM, Marriott M, Robb J, Begin H, Young LT (2002) Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. Acta Psychiatr Scand 105:427–430

    Article  CAS  PubMed  Google Scholar 

  • Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC (1987) The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 44:540–548

    CAS  PubMed  Google Scholar 

  • Koch S, Galloway MP (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104:135–146

    CAS  PubMed  Google Scholar 

  • Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250

    CAS  PubMed  Google Scholar 

  • Lahiri DK, Nurnberger JIJ (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res 19:5444

    CAS  PubMed  Google Scholar 

  • Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM (1982) Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 39:879–883

    CAS  PubMed  Google Scholar 

  • Lewis JL, Winokur G (1982) The induction of mania. A natural history study with controls. Arch Gen Psychiatry 39:303–306

    CAS  PubMed  Google Scholar 

  • Lin CN, Tsai SJ, Hong CJ (2001) Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders. Neuropsychobiology 44:118–121

    Article  CAS  PubMed  Google Scholar 

  • Macciardi F, Petronis A, Van Tol H, Marino C, Cavallini M, Smeraldi E, Kennedy J (1994) Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred. Arch Gen Psychiatry 51:288–293

    CAS  PubMed  Google Scholar 

  • Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, Smeraldi E, Kaneva R, Adolfsson R, Nylander PO, Blackwood D, Muir W, Papadimitriou GN, Dikeos D, Oruc L, Segman RH, Ivezic S, Aschauer H, Ackenheil M, Fuchshuber S, Dam H, Jakovljevic M, Peltonen L, Hilger C, Hentges F, Staner L, Milanova V, Jazin E, Lerer B, Van Broeckhoven C, Mendlewicz J (2002) Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European multicenter association study of affective disorders. Am J Med Genet 114:177–185

    Article  PubMed  Google Scholar 

  • Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P, Rupprecht R, Bondy B (2001) Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303:119–122

    Article  CAS  PubMed  Google Scholar 

  • Muglia P, Petronis A, Mundo E, Lander S, Cate T, Kennedy JL (2002) Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Mol Psychiatry 7:860–866

    Article  CAS  PubMed  Google Scholar 

  • Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL (2001) The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder. Arch Gen Psychiatry 58:539–544

    Article  CAS  PubMed  Google Scholar 

  • Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P (1998) Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8:221–225

    CAS  PubMed  Google Scholar 

  • Ni X, Trakalo JM, Mundo E, Lee L, Parikh S, Kennedy JL (2002) Family-based association study of the serotonin-2A receptor gene (5-HT2A) and bipolar disorder. Neuromolecular Med 2:251–259

    Article  CAS  PubMed  Google Scholar 

  • O’Reilly RL, Bogue L, Singh SM (1994) Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 36:467–471

    Article  CAS  PubMed  Google Scholar 

  • Orsini A (1987) Antidepressant responses and segregation analyses in affective families. In: Racagni G, Smeraldi E (eds) Anxious depression: assessment and treatment. Raven, New York

  • Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM (1998) Ultra–ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 3:346–349

    Article  CAS  PubMed  Google Scholar 

  • Pare CM, Mack JW (1971) Differentiation of two genetically specific types of depression by the response to antidepressant drugs. J Med Genet 8:306–309

    CAS  PubMed  Google Scholar 

  • Post RM (1992) The psychobiology of dysphoric mania. Clin Neuropharmacol 15:624A–625A

    PubMed  Google Scholar 

  • Post RM, Kotin J, Goodwin FK (1974) The effects of cocaine on depressed patients. Am J Psychiatry 131:511–517

    CAS  PubMed  Google Scholar 

  • Preisig M, Bellivier F, Fenton BT, Baud P, Berney A, Courtet P, Hardy P, Golaz J, Leboyer M, Mallet J, Matthey ML, Mouthon D, Neidhart E, Nosten-Bertrand M, Stadelmann-Dubuis E, Guimon J, Ferrero F, Buresi C, Malafosse A (2000) Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 157:948–955

    Article  CAS  PubMed  Google Scholar 

  • Prien RF, Caffey EM Jr, Klett CJ (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 28:337–341

    CAS  PubMed  Google Scholar 

  • Ranade SS, Mansour H, Wood J, Chowdari KV, Brar LK, Kupfer DJ, Nimgaonkar VL (2003) Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder. Am J Med Genet 121B:28–34

    Article  PubMed  Google Scholar 

  • Rietschel M, Schorr A, Albus M, Franzek E, Kreiner R, Held T, Knapp M, Muller DJ, Schulze TG, Propping P, Maier W, Nothen MM (2000) Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls. Am J Med Genet 96:310–311

    Article  CAS  PubMed  Google Scholar 

  • Risch N (1990) Linkage strategies for genetically complex traits:I. Multilocus models. Am J Med Genet 46:222–228

    CAS  Google Scholar 

  • Rousseva A, Henry C, van den Bulke D, Fournier G, Laplanche JL, Leboyer M, Bellivier F, Aubry JM, Baud P, Boucherie M, Buresi C, Ferrero F, Malafosse A (2003) Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J 3:101–104

    Article  CAS  PubMed  Google Scholar 

  • Sabol SZ, Hu S, Hamer D (1998) A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273–279

    Article  CAS  PubMed  Google Scholar 

  • Sederer LI (1986) Depression. In: Sederer LI (ed) Inpatients psychiatry diagnosis and treatment. William and Wilkins, Baltimore, p 20

  • Serretti A, Franchini L, Gasperini M, Rampoldi R, Smeraldi E (1998) Mode of inheritance in mood disorders families according to fluvoxamine response. Acta Psychiatr Scand 98:443–450

    CAS  PubMed  Google Scholar 

  • Serretti A, Cusin C, Lorenzi C, Lattuada E, Lilli R, Smeraldi E (2000) Serotonin-2a receptor gene is not associated with symptomatology of schizophrenia. Am J Med Genet 96:84–87

    Article  CAS  PubMed  Google Scholar 

  • Serretti A, Lilli R, Lorenzi C, Lattuada E, Smeraldi E (2001a) DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. Am J Med Genet 105:283–290

    Article  CAS  PubMed  Google Scholar 

  • Serretti A, Zanardi R, Rossini D, Cusin C, Lilli R, Smeraldi E (2001b) Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry 6:586–592

    Article  CAS  PubMed  Google Scholar 

  • Serretti A, Cristina S, Lilli R, Cusin C, Lattuada E, Lorenzi C, Corradi B, Grieco G, Costa A, Santorelli F, Barale F, Nappi G, Smeraldi E (2002a) Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet 114:361–369

    PubMed  Google Scholar 

  • Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E (2002b) Serotonin transporter gene (5-httlpr) and major psychoses. Mol Psychiatry 7:95–99

    Article  CAS  PubMed  Google Scholar 

  • Serretti A, Lilli R, Smerladi E (2002c) Pharmacogenetics in affective disorders. Eur J Pharmacol 438:117–128

    Article  CAS  PubMed  Google Scholar 

  • Serretti A, Lorenzi C, Lilli R, Mandelli L, Pirovano A, Smeraldi E (2002d) Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants. Am J Med Genet 114:370–379

    Article  PubMed  Google Scholar 

  • Serretti A, Artioli P, Zanardi R, Rossini D (2003a) Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 27:751–757

    Article  CAS  PubMed  Google Scholar 

  • Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, Lilli R, Pirovano A, Catalano M, Smeraldi E (2003b) SSRIs antidepressant activity is influenced by Gbeta3 variants. Eur Neuropsychopharmacol 13:117–122

    Article  CAS  PubMed  Google Scholar 

  • Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516

    CAS  PubMed  Google Scholar 

  • Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM (1997) Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69:71–77

    Article  CAS  PubMed  Google Scholar 

  • van Scheyen JD, van Kammen DP (1979) Clomipramine-induced mania in unipolar depression. Arch Gen Psychiatry 36:560–565

    PubMed  Google Scholar 

  • Van Tol H, Bunzow J, Guan H, Sunahara R, Seeman P, Niznik H, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610–614

    Article  PubMed  Google Scholar 

  • Wehr TA, Goodwin FK (1987) Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144:1403–1411

    CAS  PubMed  Google Scholar 

  • Whitworth TL, Herndon LC, Quick MW (2002) Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons. J Neurosci 22:RC192

    PubMed  Google Scholar 

  • Willner P (1995) Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 921–931

  • Zwicker AP, Calil HM (1986) The effects of REM sleep deprivation on striatal dopamine receptor sites. Pharmacol Biochem Behav 24:809–812

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, School of Medicine, Vita-Salute University San Raffaele, Via Stamira D’Ancona 20, Milan, 20127, Italy

    Alessandro Serretti, Paola Artioli, Raffaella Zanardi, Cristina Lorenzi, David Rossini, Cristina Cusin, Alessia Arnoldi & Marco Catalano

  2. Institute of Psychiatry, University of Bologna, Bologna, Italy

    Paola Artioli & Cristina Lorenzi

Authors
  1. Alessandro Serretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Artioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raffaella Zanardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristina Lorenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Rossini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cristina Cusin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alessia Arnoldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marco Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Serretti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serretti, A., Artioli, P., Zanardi, R. et al. Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. Psychopharmacology 174, 504–511 (2004). https://doi.org/10.1007/s00213-004-1948-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-1948-x

Keywords

Search

Navigation